Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related Donor Transplants-Reference-Cited by-同舟云学术

Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related Donor Transplants

Published:2008-09 Issue:9 Volume:14 Page:985-992
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Majhail Navneet S.,Brunstein Claudio G.,McAvoy Sarah,DeFor Todd E.,Al-Hazzouri Ahmed,Setubal Daniela,Arora Mukta,Le Chap T.,Wagner John E.,Weisdorf Daniel J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference18 articles.

1. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT;Sorror;Blood,2005

2. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences;Sorror;Blood,2007

3. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation;Sorror;J Clin Oncol,2007

4. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning;Barker;Blood,2003

5. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease;Brunstein;Blood,2007

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation;Cancers;2024-01-25

2. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy;American Journal of Hematology;2024-01-02

3. Medical emergencies in pediatric blood & marrow transplant and cellular therapies;Frontiers in Pediatrics;2023-02-07

4. Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation;European Journal of Haematology;2022-10-21

5. Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups;European Journal of Haematology;2022-09-10